Emerging roles of E2Fs in cancer: an exit from cell cycle control

HZ Chen, SY Tsai, G Leone - Nature reviews cancer, 2009 - nature.com
Mutations of the retinoblastoma tumour suppressor gene (RB1) or components regulating
the RB pathway have been identified in almost every human malignancy. The E2F …

Defining stem cell dynamics and migration during wound healing in mouse skin epidermis

M Aragona, S Dekoninck, S Rulands, S Lenglez… - Nature …, 2017 - nature.com
Wound healing is essential to repair the skin after injury. In the epidermis, distinct stem cells
(SCs) populations contribute to wound healing. However, how SCs balance proliferation …

E2F7− EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression

R Yang, M Wang, G Zhang, Y Bao, Y Wu, X Li… - British journal of …, 2020 - nature.com
Background E2F transcription factors are considered to be important drivers of tumour
growth. E2F7 is an atypical E2F factor, and its role in glioblastoma remains undefined …

Large-scale RNA-Seq transcriptome analysis of 4043 cancers and 548 normal tissue controls across 12 TCGA cancer types

L Peng, XW Bian, DK Li, C Xu, GM Wang, QY Xia… - Scientific reports, 2015 - nature.com
Abstract The Cancer Genome Atlas (TCGA) has accrued RNA-Seq-based transcriptome
data for more than 4000 cancer tissue samples across 12 cancer types, translating these …

E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression

LA Carvajal, PJ Hamard, C Tonnessen… - Genes & …, 2012 - genesdev.cshlp.org
The p53 tumor suppressor protein is a transcription factor that exerts its effects on the cell
cycle via regulation of gene expression. Although the mechanism of p53-dependent …

A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma

Y Ma, H Lin, P Wang, H Yang, J Yu, H Tian, T Li, S Ge… - Acta Biomaterialia, 2023 - Elsevier
MicroRNA (miRNA)-based gene therapy is a robust approach to treating human cancers.
However, the low target specificity and safety issues associated with viral vectors have …

MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7

YY Ye, JW Mei, SS Xiang, HF Li, Q Ma, XL Song… - Cell Death & …, 2018 - nature.com
Gallbladder carcinoma (GBC), the most common malignant tumour of the bile duct, is highly
aggressive and has a poor prognosis. MicroRNA-30a-5p (miR-30a-5p) is an important …

E2F8 as a novel therapeutic target for lung cancer

SA Park, J Platt, JW Lee… - Journal of the …, 2015 - academic.oup.com
Abstract Background: The E2F members have been divided into transcription activators
(E2F1-E2F3) and repressors (E2F4-E2F8). E2F8 with E2F7 has been known to play an …

[HTML][HTML] E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter

J Chu, Y Zhu, Y Liu, L Sun, X Lv, Y Wu, P Hu, F Su… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract About 50–70% of breast cancers are estrogen receptor α (ERα) positive and most of
them are sensitive to endocrine therapy including tamoxifen. However, one third of these …

Royal jelly proteins and their derived peptides: Preparation, properties, and biological activities

S Li, L Tao, X Yu, H Zheng, J Wu… - Journal of Agricultural and …, 2021 - ACS Publications
Royal jelly, also called bee milk, is a source of high-quality proteins. Royal jelly proteins
serve as not only a rich source of essential amino acids and functional donors but also an …